A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer

Clinical trial NCT00972309 · COMPLETED

Trial details

NCT number: NCT00972309
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Specific Antigens Prostate Neoplasms

Start date: 2009-05-11
Primary completion: 2015-02-04
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.